Immune response to B19 parvovirus and an antibody defect in persistent viral infection.

B19 parvovirus has been shown to persist in some immunocompromised patients, and treatment with specific antibodies can lead to decreased quantities of circulating virus and hematologic improvement. A defective immune response to B19 parvovirus in these patients was shown by comparison of results us...

Celý popis

Podrobná bibliografie

Vydáno v:	J Clin Invest
Hlavní autoři:	Kurtzman, G J, Cohen, B J, Field, A M, Oseas, R, Blaese, R M, Young, N S
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Clinical Investigation 1989
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC329767/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2551923/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114274
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!